Specialties
Industry Update
Dapagliflozin: The Multifaceted SGLT2i Backed by CVD-REAL Nordic Results
BY: Michelle LeeJun 13, 2025

Popular Story
No More Itch – Uncovering Urticaria and Its Clinical Management
  • Dr. Roy Lau
  • Jun 13, 2025
What Should We Know About Anxiety Disorder?
  • Dr. Roy Lau
  • Apr 11, 2025
Uncovering the Art of Perfect Matching – A Review on Precision Oncology
  • Dr. Roy Lau
  • Feb 17, 2025
Uncovering the Tricks of the Silent Thief of Sight
  • Dr. Roy Lau
  • Dec 19, 2024
Gain Without Pain – Revisiting the Pain Management in Rheumatoid Arthritis
  • Dr. Roy Lau
  • Oct 22, 2024
What’s New in Coronary Artery Disease?
  • Dr. Roy Lau
  • Aug 20, 2024
You May Be Interested In
Clinical Application of Durvalumab in Unresectable Locally Advanced Non-small Cell Lung Cancer
Jason ChowSep 16, 2020
Be Smart in Preventing Venous Thromboembolism
Dr. Roy LauMar 22, 2023
Energising the Well-being of Disease-related Malnourished Patients – The Clinical Issues of Parenteral Nutrition
Dr. Roy LauFeb 6, 2024
Controlling Major Depressive Disorder without Tuning Down Emotions
Dr. Roy LauAug 11, 2023
Specialties
More Contents
©2025 V-Pulse. All rights reserved.